Please use this identifier to cite or link to this item: http://hdl.handle.net/10662/20102
Title: Genetic variants in arachidonic acid pathway genes associated with NSAIDs-exacerbated respiratory disease
Authors: Ayuso Parejo, Pedro
Plaza Serón, María Carmen
Blanca López, Natalia
Doña, Inmaculada
Campo, Paloma
Canto, Gabriela
Laguna, Jose Julio
Bartra, Joan
Soriano Gomis, Victor
Blanca Gómez, Miguel
Cornejo García, José Antonio
Perkins, James R.
Keywords: Ácido araquidónico;Arachidonic acid;AINEs;Polimorfismos;NSAIDs;Polymorphisms;Copy number variations;Variaciones del número de copias;Hypersensitivity drug reactions;Reacciones de hipersensibilidad a los medicamentos;NSAIDs-exacerbated respiratory disease;Enfermedad respiratoria exacerbada por AINE
Issue Date: 2015
Publisher: Future Medicine
Abstract: Aim: NSAIDs are the most frequent cause of hypersensitivity drug reactions. We have examined the association between NSAIDs-exacerbated respiratory disease (NERD) and genetic variants in arachidonic acid metabolism genes. Patients & methods: We included 250 NERD patients, 260 NSAID-tolerant asthmatic (NTA) subjects and 315 healthy controls. Results: Significant associations with NERD were identified for: ALOX15 rs3892408 C/C homozygous genotype (NERD vs NTA; p = 0.0001, pc = 0.0011; NERD vs controls; p = 0.0001, pc = 0.0011), PTGS-1 rs5789 A/A homozygous genotype (NERD vs NTA; p = 0.0001, pc = 0.0011; NERD vs controls; p = 0.0001, pc = 0.0011), PTGS- 1 rs10306135 A/A homozygous genotype (NERD vs NTA; p = 0.0009, pc = 0.0091; NERD vs controls; p = 0.0064, pc = 0.045). Differences in ALOX5 copy number variations were also found (NERD vs NTA; p = 0.010; NERD vs controls; p = 0.0001). Conclusion: These results improve our understanding of the underlying mechanisms of NERD and may help develop a predictive test for this pathology
URI: http://hdl.handle.net/10662/20102
ISSN: 1462-2416
DOI: 10.2217/PGS.15.43
Appears in Collections:DTMQU - Artículos

Files in This Item:
File Description SizeFormat 
pgs_15_43.pdf1,19 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons